John Lister-James

Summary

Publications

  1. ncbi Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent
    John Lister-James
    Avid Radiopharmaceuticals, Philadelphia, PA
    Semin Nucl Med 41:300-4. 2011

Detail Information

Publications1

  1. ncbi Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent
    John Lister-James
    Avid Radiopharmaceuticals, Philadelphia, PA
    Semin Nucl Med 41:300-4. 2011
    ..Clinical studies have demonstrated a clear correlation between in vivo PET imaging with florbetapir F-18 and postmortem histopathologic quantitation of β-amyloid in the brain...